Altiratinib (DCC-2701)(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor, effectively reduce tumor burden in vivo and block c-MET pTyr(1349)-mediated signaling, cell growth and migration as compared with an HGF antagonist in vitro.
Molecular Weight:
510.46
Purity:
98.98%
CAS Number:
[1345847-93-9]
Formula:
C26H21F3N4O4
Target:
Tie-2|||c-Met/HGFR|||VEGFR|||FLT|||Trk receptor
T2054
* VAT and and shipping costs not included. Errors and price changes excepted